Edition:
United States

Progenics Pharmaceuticals Inc (PGNX.OQ)

PGNX.OQ on NASDAQ Stock Exchange Global Select Market

8.39USD
22 Jun 2018
Change (% chg)

$-0.08 (-0.94%)
Prev Close
$8.47
Open
$8.46
Day's High
$8.49
Day's Low
$8.35
Volume
47,596
Avg. Vol
346,212
52-wk High
$9.11
52-wk Low
$4.61

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.18 December 22 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.40 1.40 1.40 1.40

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 5 4.35 6.46 3.30 --
Quarter Ending Sep-18 5 7.49 10.92 4.90 --
Year Ending Dec-18 5 25.47 38.00 17.74 82.35
Year Ending Dec-19 5 79.90 101.80 56.49 112.60
Earnings (per share)
Quarter Ending Jun-18 5 -0.18 -0.16 -0.21 --
Quarter Ending Sep-18 5 -0.11 -0.02 -0.18 --
Year Ending Dec-18 5 -0.62 -0.39 -0.79 -0.09
Year Ending Dec-19 4 -0.09 0.06 -0.24 0.28

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 4.35 3.19 1.16 26.69
Quarter Ending Dec-17 3.20 3.89 0.69 21.53
Quarter Ending Sep-17 3.52 2.70 0.82 23.38
Quarter Ending Jun-17 3.67 2.77 0.91 24.76
Quarter Ending Mar-17 4.49 2.35 2.15 47.75

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 4.35 4.35 4.35 6.03 --
Quarter Ending Sep-18 7.49 7.49 7.49 13.72 --
Year Ending Dec-18 25.47 25.47 25.47 38.59 82.35
Year Ending Dec-19 79.90 79.90 79.90 87.93 112.60

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings